Finally, to confirm binding of IER5 to the Cdc25B promoter in AML-derived ALDHhi/CD34+ cells, we also performed ChIP analysis in ALDHhi/CD34+ cells purified from one AML patient (AML: M1) (Fig. 7). The gene discussed is CD34; the disease is acute myeloid leukemia.